Register entry

BASF Corporation

Data as of · How to read this entry

Registered sites
6
Active NDC listings
24
Labeller names
2
Live patents
0
Countries
4
Base
United States
Authorisation

Registered operations

Active ingredient (API) manufacture6
Sites

Registered establishments

6
EstablishmentAddressRegistered forFEI / DUNS
BASF SECarl-Bosch-Str. 38, Ludwigshafen am Rhein, 67063, Germany (DEU)Active ingredient (API) manufacture3002903906315000554
BASF A/SMalmparken 5, Ballerup, DK-2750, Denmark (DNK)Active ingredient (API) manufacture1000474076311500297
BASF Pharma (Callanish) LimitedRegistrant: BASF CorporationBreasclete Isle of Lewis Western Isles, Isle of Lewis, HS2 9ED, United Kingdom (GBR)Active ingredient (API) manufacture3007497738347031333
BASF Corporation5738 County Road 4, Bishop, Texas (TX) 78343-3308, United States (USA)Active ingredient (API) manufacture3001451837014403088
BASF Corporation361 Sheep Pasture Road, East Setauket, New York (NY) 11733, United States (USA)Active ingredient (API) manufacture1000521506788535396
BASF Corporation8404 Highway 75, Geismar, Louisiana (LA) 70734, United States (USA)Active ingredient (API) manufacture2316568040776809
Catalogue

Drug listings by form and route

24

24 active NDC listings: 22 bulk ingredient, 2 drug for further processing. By marketing category: BULK INGREDIENT 20, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 2, DRUG FOR FURTHER PROCESSING 2.

Dosage formNDCs
powder19
liquid4
syrup1
RouteNDCs
Labeller name on the listingNDCs
basf corporation19
basf se5
Catalogue

Marketed products

24
BrandGeneric nameForm / routeNDC
-Dexpanthenolsyrup48041-0003BULK INGREDIENT
-IBUPROFEN DC85Wpowder10117-0931BULK INGREDIENT
-Ibuprofenpowder10117-0926BULK INGREDIENT
-Ibuprofenpowder10117-0930BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Ibuprofenpowder10117-0936BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Ibuprofenpowder10117-0952BULK INGREDIENT
-Kollisolv PEG 3350powder70177-0001BULK INGREDIENT
-L-Menthol Pharmapowder48041-0001BULK INGREDIENT
-L-Menthol Pharma Flakespowder48041-0002BULK INGREDIENT
-Octinoxateliquid48041-1001BULK INGREDIENT
-Octinoxate, Avobenzoneliquid10117-3613DRUG FOR FURTHER PROCESSING
-PVP Iodine 30/60powder70177-0002BULK INGREDIENT
-Poloxaleneliquid10117-0218BULK INGREDIENT
-Poloxaleneliquid10117-2019BULK INGREDIENT
-Racemic Ibuprofen Lysinatepowder48041-0004BULK INGREDIENT
-Sodium Ibuprofen Dihydratepowder10117-0990BULK INGREDIENT
-ZINC OXIDEpowder10117-3009DRUG FOR FURTHER PROCESSING
-Zinc Oxidepowder10117-3003BULK INGREDIENT
-Zinc Oxidepowder10117-3004BULK INGREDIENT
-Zinc Oxidepowder10117-3006BULK INGREDIENT
-Zinc Oxidepowder10117-3007BULK INGREDIENT
-Zinc Oxidepowder10117-3008BULK INGREDIENT
-Zinc Oxidepowder10117-3010BULK INGREDIENT
-Zinc Oxidepowder10117-3011BULK INGREDIENT
Neighbours

Registered in the same town

4
Compare

Comparable companies in United States

Enquiry

Common questions

Is BASF Corporation FDA approved?
BASF Corporation holds 6 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are BASF Corporation's drugs manufactured?
At registered sites in Germany, Denmark, the United Kingdom, the United States. The FDA register lists Ludwigshafen am Rhein; Ballerup; Isle of Lewis; Bishop, TX; East Setauket, NY; Geismar, LA. Registered operations: active ingredient (API) manufacture.
What drugs does BASF Corporation make?
24 products are listed under BASF Corporation in the openFDA NDC Directory, most often as powder; liquid; syrup. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.